Literature DB >> 21814284

Blood pressure re-screening for healthy adults: what is the best measure and interval?

O Takahashi1, P P Glasziou, R Perera, T Shimbo, T Fukui.   

Abstract

Blood pressure (BP) screening is important to identify those at risk of cardiovascular disease, but there has been little data on the appropriate interval of screening. We aimed to evaluate the optimal interval and the best measure for BP re-screening by estimating the long-term, true change variance ('signal') and short-term, within-person variance ('noise'). Study design was a cohort study from 2005 to 2008. Target population was Japanese healthy adults not taking antihypertensive medication at baseline, in a teaching hospital. We measured annually the systolic BP (SBP) and the diastolic BP (DBP), and calculated the pulse pressure (PP) and the mean arterial pressure (MAP). A total of 15,055 individuals (51% male) with a mean age of 49 years had annual check-ups. Short-term coefficient of variation was lowest for MAP at 5.2%, followed by SBP (5.7%) and DBP (5.8%), and highest for PP (12%). After 3 years, the 'signal' of true BP changes of only SBP and MAP equaled the 'noise' of BP measurement; however, it was larger for those with higher initial BPs. SBP or MAP appears to be a better screening measure. The optimal interval should be 3 years or more, with SBP<130 mm Hg and 2 years for those with SBP ≥ 130 mm Hg.

Entities:  

Mesh:

Year:  2011        PMID: 21814284     DOI: 10.1038/jhh.2011.72

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

1.  Assessment of Visit-to-Visit Blood Pressure Variability in Adults With Optimal Blood Pressure: A New Player in the Evaluation of Residual Cardiovascular Risk?

Authors:  Menghui Liu; Xiaohong Chen; Shaozhao Zhang; Junfan Lin; Lichun Wang; Xinxue Liao; Xiaodong Zhuang
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

2.  5-year versus risk-category-specific screening intervals for cardiovascular disease prevention: a cohort study.

Authors:  Joni V Lindbohm; Pyry N Sipilä; Nina J Mars; Jaana Pentti; Sara Ahmadi-Abhari; Eric J Brunner; Martin J Shipley; Archana Singh-Manoux; Adam G Tabak; Mika Kivimäki
Journal:  Lancet Public Health       Date:  2019-04

3.  A comparative analysis and review of how national guidelines for chronic disease monitoring are made in low- and middle-income compared to high-income countries.

Authors:  Elton Mukonda; Maia Lesosky
Journal:  J Glob Health       Date:  2021-09-04       Impact factor: 4.413

Review 4.  Blood pressure variability and cardiovascular disease: systematic review and meta-analysis.

Authors:  Sarah L Stevens; Sally Wood; Constantinos Koshiaris; Kathryn Law; Paul Glasziou; Richard J Stevens; Richard J McManus
Journal:  BMJ       Date:  2016-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.